ChromoGenics AB (OSTO:CHRO) Total Liabilities : kr61.20 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ChromoGenics AB Total Liabilities?

ChromoGenics AB's Total Liabilities for the quarter that ended in Jun. 2024 was kr61.20 Mil.

ChromoGenics AB's quarterly Total Liabilities increased from Dec. 2023 (kr96.41 Mil) to Mar. 2024 (kr106.98 Mil) but then declined from Mar. 2024 (kr106.98 Mil) to Jun. 2024 (kr61.20 Mil).

ChromoGenics AB's annual Total Liabilities declined from Dec. 2021 (kr102.74 Mil) to Dec. 2022 (kr91.01 Mil) but then increased from Dec. 2022 (kr91.01 Mil) to Dec. 2023 (kr96.41 Mil).

ChromoGenics AB Total Liabilities Historical Data

The historical data trend for ChromoGenics AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromoGenics AB Total Liabilities Chart

ChromoGenics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

89.45

92.90

102.74

91.01

96.41

ChromoGenics AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															92.50	99.39	96.41	106.98	61.20

ChromoGenics AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ChromoGenics AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	27.362	+	(66.621	+	2.425
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	96.41

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	139.163	-	42.755
	=	96.41

ChromoGenics AB's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	33.835	+	(24.94	+	2.424
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	61.20

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	129.001	-	67.802
	=	61.20

ChromoGenics AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of ChromoGenics AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ChromoGenics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » ChromoGenics AB (OSTO:CHRO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

384:Germany

Address

Ullforsgatan 15, Uppsala, SWE, 752 28

Website

http://www.chromogenics.com

ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.

ChromoGenics AB Headlines

From GuruFocus

Chromocell Announces Stock Repurchase Plan

By Marketwired • 08-07-2024